These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 7836413)

  • 1. Association of the invariant chain with major histocompatibility complex class I molecules directs trafficking to endocytic compartments.
    Sugita M; Brenner MB
    J Biol Chem; 1995 Jan; 270(3):1443-8. PubMed ID: 7836413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Major histocompatibility complex class II compartments in human B lymphoblastoid cells are distinct from early endosomes.
    Peters PJ; Raposo G; Neefjes JJ; Oorschot V; Leijendekker RL; Geuze HJ; Ploegh HL
    J Exp Med; 1995 Aug; 182(2):325-34. PubMed ID: 7629497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trafficking of major histocompatibility complex class II molecules through intracellular compartments containing HLA-DM.
    Robbins NF; Hammond C; Denzin LK; Pan M; Cresswell P
    Hum Immunol; 1996 Jan; 45(1):13-23. PubMed ID: 8655355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poor loading of major histocompatibility complex class II molecules with endogenously synthesized short peptides in the absence of invariant chain.
    Busch R; Vturina IY; Drexler J; Momburg F; Hämmerling GJ
    Eur J Immunol; 1995 Jan; 25(1):48-53. PubMed ID: 7843252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Major histocompatibility complex class II compartments in human and mouse B lymphoblasts represent conventional endocytic compartments.
    Kleijmeer MJ; Morkowski S; Griffith JM; Rudensky AY; Geuze HJ
    J Cell Biol; 1997 Nov; 139(3):639-49. PubMed ID: 9348281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late events in the intracellular sorting of major histocompatibility complex class II molecules are regulated by the 80-82 segment of the class II beta chain.
    Tan LJ; Ceman S; Chervonsky A; Rodriguez-Paris J; Steck TL; Sant AJ
    Eur J Immunol; 1997 Jun; 27(6):1479-88. PubMed ID: 9209501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presentation of endogenous viral proteins in association with major histocompatibility complex class II: on the role of intracellular compartmentalization, invariant chain and the TAP transporter system.
    Oxenius A; Bachmann MF; Ashton-Rickardt PG; Tonegawa S; Zinkernagel RM; Hengartner H
    Eur J Immunol; 1995 Dec; 25(12):3402-11. PubMed ID: 8566030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient internalization of MHC class II-invariant chain complexes is not sufficient for invariant chain proteolysis and class II antigen presentation.
    Swier K; Miller J
    J Immunol; 1995 Jul; 155(2):630-43. PubMed ID: 7608541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytoplasmic tail-dependent localization of CD1b antigen-presenting molecules to MIICs.
    Sugita M; Jackman RM; van Donselaar E; Behar SM; Rogers RA; Peters PJ; Brenner MB; Porcelli SA
    Science; 1996 Jul; 273(5273):349-52. PubMed ID: 8662520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between invariant chain expression and major histocompatibility complex class II transport into early and late endocytic compartments.
    Romagnoli P; Layet C; Yewdell J; Bakke O; Germain RN
    J Exp Med; 1993 Mar; 177(3):583-96. PubMed ID: 8436902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mouse B lymphocyte specific endocytosis and recycling of MHC class II molecules.
    Salamero J; Humbert M; Cosson P; Davoust J
    EMBO J; 1990 Nov; 9(11):3489-96. PubMed ID: 1976509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In the absence of major histocompatibility complex class II molecules, invariant chain is translocated to late endocytic compartments by autophagy.
    Chervonsky A; Sant AJ
    Eur J Immunol; 1995 Apr; 25(4):911-8. PubMed ID: 7737293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early endosomes are required for major histocompatiblity complex class II transport to peptide-loading compartments.
    Brachet V; Péhau-Arnaudet G; Desaymard C; Raposo G; Amigorena S
    Mol Biol Cell; 1999 Sep; 10(9):2891-904. PubMed ID: 10473634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous and exogenous forms of the same antigen are processed from different pools to bind MHC class II molecules in endocytic compartments.
    Bonifaz LC; Arzate S; Moreno J
    Eur J Immunol; 1999 Jan; 29(1):119-31. PubMed ID: 9933093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extensive trafficking of MHC class II-invariant chain complexes in the endocytic pathway and appearance of peptide-loaded class II in multiple compartments.
    Castellino F; Germain RN
    Immunity; 1995 Jan; 2(1):73-88. PubMed ID: 7600303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of intracellular trafficking of human CD1d by association with MHC class II molecules.
    Kang SJ; Cresswell P
    EMBO J; 2002 Apr; 21(7):1650-60. PubMed ID: 11927549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invariant chain distinguishes between the exogenous and endogenous antigen presentation pathways.
    Teyton L; O'Sullivan D; Dickson PW; Lotteau V; Sette A; Fink P; Peterson PA
    Nature; 1990 Nov; 348(6296):39-44. PubMed ID: 2234057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation regulates the delivery of MHC class II invariant chain complexes to antigen processing compartments.
    Anderson HA; Roche PA
    J Immunol; 1998 May; 160(10):4850-8. PubMed ID: 9590232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The biogenesis of the MHC class II compartment in human I-cell disease B lymphoblasts.
    Glickman JN; Morton PA; Slot JW; Kornfeld S; Geuze HJ
    J Cell Biol; 1996 Mar; 132(5):769-85. PubMed ID: 8603911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delivery of nascent MHC class II-invariant chain complexes to lysosomal compartments and proteolysis of invariant chain by cysteine proteases precedes peptide binding in B-lymphoblastoid cells.
    Morton PA; Zacheis ML; Giacoletto KS; Manning JA; Schwartz BD
    J Immunol; 1995 Jan; 154(1):137-50. PubMed ID: 7995933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.